Test Price
2,800 AED✅ Home Collection Available
KCNH2 Gene Long QT Syndrome Type 2 Genetic Test in UAE
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Executive Summary & Core Metrics
The KCNH2 gene test utilises Next-Generation Sequencing (NGS) to identify pathogenic variants in the KCNH2 gene associated with Long QT Syndrome Type 2 (LQT2), an inherited cardiac channelopathy predisposing to life-threatening arrhythmias. This highly sensitive genetic analysis is essential for confirming clinical diagnosis, guiding beta-blocker therapy, and screening at-risk family members. Priced at 2,800 AED, the test is performed onshore under DHA licence (No. 1143) with a turnaround time of 3–4 weeks. VIP mobile phlebotomy at home is available for standard whole blood specimens.
Test Overview & Methodology
The KCNH2 NGS test analyses all coding exons, intron-exon boundaries, and detects large deletions/duplications (CNVs). This comprehensive coverage surpasses traditional Sanger sequencing, offering higher diagnostic yield. The testing is conducted at DNA Labs UAE, an ISO-accredited laboratory, ensuring rigorous quality control.
| Feature | Our KCNH2 NGS Test | Typical Single-Gene Sanger Test |
|---|---|---|
| Methodology | Next-Generation Sequencing (full gene, CNV detection) | Sanger Sequencing (targeted variants only) |
| Variant Coverage | All exons, intron‑exon boundaries, large deletions/duplications | Known familial mutation or hotspot regions |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks (often sent abroad) |
| Price | 2,800 AED (DHA‑licensed lab, ISO 9001:2015) | 3,500–5,000 AED (plus shipping) |
| Local Compliance | Full DHA/MOHAP standards, onshore processing | May lack UAE regulatory oversight |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) emphasises: “KCNH2 genetic testing must always be interpreted in conjunction with the full clinical and family history. A negative result does not exclude all forms of Long QT syndrome, and absence of a known mutation does not guarantee freedom from arrhythmic risk. All patients should maintain regular cardiology follow-up and avoid factors that could prolong the QT interval.”
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Beta‑blockers and other anti‑arrhythmics may be essential for your safety. Always discuss test results with your healthcare provider before making any treatment changes.
Safety Exclusion Criteria & Red Flags
- Exclusion Criteria: Defer testing if you received a blood transfusion or stem cell transplant within the last 3 months, as donor DNA may interfere with results.
- Emergency Red Flags: Seek immediate medical attention (call 998) if you experience unexplained fainting (syncope), seizures, rapid palpitations, or chest pain—these could signal life‑threatening arrhythmias.
Patient FAQ & Clinical Guidance
1. What does the KCNH2 genetic test detect?
It detects disease‑causing KCNH2 mutations linked to Long QT syndrome type 2. The NGS method covers all coding exons and adjacent splicing regions, revealing both point mutations and larger deletions/duplications. This provides a comprehensive molecular diagnosis compared to older, limited screening tests.
2. Is home sample collection available in the UAE?
Yes, we offer VIP mobile phlebotomy and temperature-controlled cold-chain home collection, available daily from 8 AM to 11 PM. A simple blood draw (3 mL in EDTA tube) or FTA card spot can be collected at your doorstep by a DHA-licensed phlebotomist. This ensures sample stability and rapid processing.
3. What are the implications for my family?
A positive result indicates a 50% inheritance risk for first‑degree relatives, requiring cascade genetic testing. Early identification allows proactive monitoring, beta‑blocker therapy, and lifestyle modifications to prevent sudden cardiac events. Our genetic counsellors are available to guide family screening and informed decision‑making.
UAE Regulatory & Data Privacy Adherence
Data Protection: All personal and genetic data are processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your information is encrypted, stored securely, and never shared without your explicit consent.
Clinical Safety: Patient consent and clinical testing safety adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Genetic counselling is recommended prior to testing.
Licensing: DNA Labs UAE operates under DHA Facility License No. 1143 (Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE). All services comply with UAE health authority standards.
Clinical & Logistical Metadata
| Test Name | KCNH2 Gene Long QT Syndrome Type 2 Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or FTA Card; VIP Mobile Phlebotomy available |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV detection |
| ICD-10-CM Code | I45.81 (Long QT syndrome) |
| LOINC Code | 21614-3 (Genetic test for familial disorder) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians